Chemical industry – Page 61
-
BusinessBrexit uncertainty ripples across regulation
What might leaving the EU mean for medicines regulation, the Unified Patent Court, and the UK’s participation in Reach?
-
BusinessAll part of the service
Simon Hirst, founder of contract research organisation Sygnature, is the 2016 Chemistry World entrepreneur of the year
-
-
BusinessUnpicking doctor payments
Accepting even small meals from drug industry reps appears to influence doctors’ prescription rates
-
BusinessHenkel to buy detergent maker Sun Products
€3.2bn deal boosts Henkel’s position in North American laundry care market
-
BusinessAstraZeneca licenses skin drugs to Leo
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
-
BusinessNovartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
BusinessLies and deception see Astellas UK suspended by trade body
Company promoted drugs inappropriately and misled regulators in the resulting investigation
-
-
BusinessDow to cut 2500 jobs in Corning merger
Firm will close silicones manufacturing plants in North Carolina and Japan as it absorbs former joint venture
-
BusinessSanofi and Boehringer agree €11bn asset swap
Deal swaps Sanofi’s animal health arm for Boehringer’s consumer healthcare business as both firms aim to boost scale
-
BusinessHarvard settles with ex-student over drug royalties
Student claimed university forced him to accept unfair cut in patent deal
-
Business
Teva sells off products in preparation for Allergan merger
Generics deals with Impax, Dr Reddy’s and Sagent aimed at satisfying competition authorities
-
BusinessEU poised to legislate endocrine disruptor definition
The European Commission’s newly proposed standards to identify endocrine disruptors face industry opposition
-
BusinessBASF boosts coatings with Chemetall buyout
$3.2bn purchase from Albemarle continues BASF’s efforts to expand and refocus its coatings division
-
BusinessUS biotech director accused of insider trading
Biostatistics chief at Akebia charged with securities fraud
-
CareersThe offshore chemist
Catriona Gebbie talks to Nina Notman about life as the only analytical chemist on board a North Sea oil production platform
-
BusinessMetals boss admits illegal export plot
Global Metallurgy chief conspired to export restricted metals to Iran
-
BusinessJudge voids Merck & Co’s $200m patent claim
‘Serious misconduct’ kills case over Gilead’s hepatitis C drugs
-
BusinessAdventures of an accidental entrepreneur
India needs to break out of its colonial mindset and tap into its innovative potential, says Biocon chief Kiran Mazumdar-Shaw